Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs
- PMID: 16265598
- DOI: 10.1007/s00223-005-1295-x
Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs
Abstract
We previously demonstrated that suppression of bone remodeling allows microdamage to accumulate, thereby leading to reduced bone toughness in dog bone. In this study we evaluated the relationships between bone remodeling at the iliac crest and skeletal activation frequency, microdamage accumulation, or biomechanical properties of lumbar vertebrae using the same dogs to determine whether bone remodeling at the iliac crest can predict damage accumulation and mechanical parameters of the lumbar spine following treatment with antiresorptive agents. Thirty-six female beagles, 1 to 2 years old, were divided into three groups. The control group was treated daily for 12 months with saline vehicle. The remaining two groups were treated daily with oral risedronate at a dose of 0.5 mg/kg/day, or alendronate at 1.0 mg/kg/day orally. The doses of these bisphosphonates were 5 to 6 times the clinical doses approved for treatment of osteoporosis in humans. After sacrifice, the right ilium and L2 vertebra were assigned to histomorphometry. The left ilium and L3 vertebra were used for microdamage analysis. The L4 vertebra was mechanically tested to failure in compression, and bone toughness calculated from the stress-strain curve. There was a strong positive relationship for activation frequency (Ac.f) between ilium and lumbar vertebrae (r2 = 0.82; P < 0.0001). Iliac crest Ac.f underestimates Ac.f in L2, but L2 Ac.f reaches a minimum threshold and does not decline further when iliac crest Ac.f is below 0.10/yr. Microdamage (Cr.S.Dn) accumulation at the ilium was significantly associated with increased microdamage accumulation in the L3 lumbar vertebra (r2 = 0.43, P < 0.0001). The data also show that bisphosphonate treatment increased Cr.S.Dn at a faster rate in L3 than in the iliac crest. Although bisphosphonate treatment decreased bone toughness in L4, this decrease demonstrated no relationship to decreased Ac.f in the ilium. These results clearly indicate that bone remodeling data obtained from iliac crest biopsy could be used to estimate the activation frequency and microdamage burden in the vertebral column.
Similar articles
-
Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.Bone. 2006 Oct;39(4):872-9. doi: 10.1016/j.bone.2006.04.028. Epub 2006 Jun 12. Bone. 2006. PMID: 16765660
-
Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.J Bone Miner Res. 2000 Apr;15(4):613-20. doi: 10.1359/jbmr.2000.15.4.613. J Bone Miner Res. 2000. PMID: 10780852
-
Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys.Bone. 2013 May;54(1):1-7. doi: 10.1016/j.bone.2013.01.016. Epub 2013 Jan 26. Bone. 2013. PMID: 23356990
-
Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know.Bone. 2011 Jul;49(1):56-65. doi: 10.1016/j.bone.2010.10.159. Epub 2010 Oct 16. Bone. 2011. PMID: 20955825 Review.
-
Bone microdamage: a clinical perspective.Osteoporos Int. 2009 Aug;20(8):1299-308. doi: 10.1007/s00198-009-0899-9. Epub 2009 Mar 17. Osteoporos Int. 2009. PMID: 19291343 Review.
Cited by
-
Assessment of a bone biopsy technique for measuring tiludronate in horses: a preliminary study.Can J Vet Res. 2011 Apr;75(2):128-33. Can J Vet Res. 2011. PMID: 21731184 Free PMC article.
-
Can long-term bisphosphonate use causes low-energy fractures? A case report.Osteoporos Int. 2014 Feb;25(2):773-6. doi: 10.1007/s00198-013-2428-0. Epub 2013 Jul 4. Osteoporos Int. 2014. PMID: 23824297
-
Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs.J Bone Miner Res. 2010 Jan;25(1):98-105. doi: 10.1359/jbmr.090713. J Bone Miner Res. 2010. PMID: 19580463 Free PMC article.
-
Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate.Osteoporos Int. 2009 Jun;20(6):887-94. doi: 10.1007/s00198-008-0754-4. Epub 2008 Oct 11. Osteoporos Int. 2009. PMID: 18850239 Free PMC article.
-
Role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw.Clin Oral Investig. 2016 Nov;20(8):2251-2258. doi: 10.1007/s00784-016-1718-2. Epub 2016 Jan 22. Clin Oral Investig. 2016. PMID: 26795624
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources